Coronavirus (COVID-19) pandemic

Latest News

April 3, 2020

International Narcotics Control Board postpones 128th session; ongoing support to governments for international licit trade in controlled substances continues

VIENNA, 3 April - The International Narcotics Control Board is postponing its 128th session, scheduled to take place from 4 to 15 May 2020, in view of the COVID-19 pandemic. Alternate dates for the session of the drug control treaty monitoring body are being identified.

March 24, 2020

I2ES Forum - Platform for exchanging ideas on contingency measures during COVID-19

VIENNA, 24 March - In view of the COVID-19 pandemic declared by the World Health Organization, the President of the International Narcotics Control Board (INCB), Mr Cornelis P. de Joncheere, in a message published on 17 March 2020... [Read more]

March 17, 2020

The International Narcotics Control Board calls on governments to ensure continued access to controlled medicines for pain relief and palliative care and for mental health and neurological conditions during the COVID-19 pandemic

VIENNA, 17 March (United Nations Information Service) - The International Narcotics Control Board is calling on governments to ensure that the international supply chains of controlled substances, such as pain relief medicines, are not disrupted by measures put in place to counter the COVID-19 pandemic and contain further transmission of the virus. ...[Read more]

News Archive

Cornelis P. de Joncheere, INCB President

 

Our Mission

The International Narcotics Control Board (INCB) is the independent and quasi-judicial monitoring body for the implementation of the United Nations international drug control conventions. It was established in 1968 in accordance with the Single Convention on Narcotic Drugs, 1961. It had predecessors under the former drug control treaties as far back as the time of the League of Nations.

©1995-2020 International Narcotics Control Board